← Scroll for more →
Olema Pharmaceuticals, Inc. (OLMA)
Pharmaceutical Preparations
Latest Price
$7.04
TTM P/E
--
Normalized P/E
--
TTM Div Yield
--
Fwd Div Yield
--
Book Value
4.93
P/B Ratio
1.43
Institutional Ownership
100.0% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| FMR LLC | 12.14M | $151.0M | 13.89% | +1.76M | 2026-06-30 |
| Paradigm Biocapital Advisors LP | 8.67M | $108.0M | 9.91% | +650.0K | 2026-06-30 |
| Jupiter Topco LLC | 7.09M | $88.0M | 8.11% | -- | 2026-06-30 |
| Bain Capital Life Sciences Investors, LLC | 7.09M | $88.0M | 8.10% | -388.0K | 2026-06-30 |
| BlackRock, Inc. | 6.71M | $83.0M | 7.68% | +1.06M | 2026-06-30 |
| Bvf Inc | 5.30M | $66.0M | 6.06% | -- | 2026-06-30 |
| Siren, L.L.C. | 4.86M | $60.0M | 5.55% | +100.0K | 2026-06-30 |
| State Street Corp | 4.32M | $53.0M | 4.94% | +378.2K | 2026-06-30 |
| Vanguard Capital Management LLC | 3.34M | $41.0M | 3.82% | +257.7K | 2026-06-30 |
| Logos Global Management LP | 3.21M | $40.0M | 3.67% | -- | 2026-06-30 |